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Summary 
A cold-adapted, nonvirulent variant  of the Armstrong strain of lymphocytic 
ehoriomeningitis virus was isolated from infected L929 cells maintained at  25 ° C. 
This variant,  designated P 17, was capable of replicating in the central nervous 
system of mice without causing disease and conferring immunity to back challenge 
with the parental  strain. 
, 
Lymphocyt ic  ehoriomeningitis virus (LC1V[V) is the prototypic Arenavirus (16). 
As a group, the Arenaviridae have a single-stranded, negative-sense RNA genome 
with a molecular weight between 4---5 X 108 (1). The genome has two segments, 
large (L) and small (S) and the viruses can genetically reassert (1). Recently (11), 
it was suggested tha t  the L RNA gene products determine the plaque phenotype 
of LCMV while the S RNA gene products determine pathogenic potential. LCMV 
has been studied for many  years as a model of acute viral disease and viral 
persistence (7, 10, 12, 13, 17). Adult mice inoculated intracerebrally (i.e.) with 
LCMV die of acute aseptic meningitis, while newborn mice survive an indentieal 
inoculum. Infection of the newborn results fix a persistent infection tha t  lasts 
the life of the animal and appears to be due to tolerance of the celt mediated 
immune system (2). I n  an a t t empt  to better  understand the pathogenic po~nt ia l  
of LC}IV, we describe in this report  the isolation and partial  characterization of 
a var iant  of LCMV tha t  is nonvirulent for adult mice. 
The Armstrong strain of LCMV was obtained from R. M. W~LsH, J~., Scripps 
Clinic and Research Foundation, La golla, CA. Virus was plaque assayed on 
MDCK cells (C. J .  PFAC, Rensselaer Polytechnic Insti tute,  Troy, NY) using a 
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0.5 percent agarose overlay as described by ])UTK0 and PFAU (3). The parent 
LCMV was neurovirulent having an LDs0 titer of 10-5.50/0.03 ml by i. c. inoculation 
into 4---6 week old Swiss-Webster (SW) mice. In  preliminary experiments, we 
noted that  L929 cells (American Type Culture Collection, Rockville, I~{D) infected 
with LCM~" and incubated at 25 ° C released virus continuously for 16---18 days 
until the monolayers began to degenerate. In  an attempt to isolate variant viruses, 
we serially passaged LCMV in L929 cells at 25 ° C every 14 days. Each passage 
was tested for virulence by i.e. inoculation into SW mice. No change in the 
virulence of the virus propagated at 25°C was noted until passage 15. This 
passage showed reduced virulence (LD5o = 10-4-1°/0.03 rot) compared to the 
parent virus. Passage 16 showed a significant reduction in neurovirutenee (LDs0 
= 10-L90/0.03 ml), and at passage 17 we were unable to establish an LD50 as no 
animals died following injection of up to 2000 PFU of the virus. When we 
examined the efficiency of plaquing (EOP) at 250/35 ° C for each of these passages 
we found that  the ability of passage 15 to form plaques at these two temperatures 
was essentially equivalent. (EOP = 0.90) and virtually indentieal to the parent 
virus (EOP = 0.95). Passage 16 had an EOP of 0.32, and passage 17 (P17) had 
an EOP = 0.15, indicating that  concomitant with its loss of virulence it had lost 
most but not all of its ability to form plaques at 35 ~ C. P17 was then plaque 
purified by two passages in MDCK cells. These plaques were primarily of the 
turbid type (5, 6). 
Preliminary studies showed that  mice were unaffected following i. c. inoculation 
with 1000 PFU of P 17 which represented approximately 500 LDao of the parental 
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Fig. I. Replication of P 17 (o o) and Armstrong LCMV (= .) in mouse brain 
assayed at 25 ° and 35 ° C, respectively, on MDCI~ cells. UN undetectablc 
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days  post - infect ion,  an imals  were sacrificed and  one-half  of the  bra in  was 
homogenized  (20 percen t  w/v in Ea r l e ' s  ba lanced  sal t  so lut ion wi th  1 pe rcen t  
fe ta l  bovine  serum) and  assayed  at, 25°C  for infect ious virus.  The r ema in ing  
b ra in  half  was f ixed with  formal in  and  examined  for histologie evidence of 
infection.  Fig.  1 compares  the  repl ica t ion  of P 17 in mouse bra in  assayed  a t  25 ° C 
to the  kinet ics  of virus  rep l ica t ion  in a group of mice infected wi th  100 LDs0 of 
p a r e n t a l  LCMV. P17 was recoverable  a t  1 d a y  post- infect ion,  the  virus  t i t e r  
peaked  a t  5 days  post- infect ion,  and  had  rel ,urned to unde tee tab le  levels b y  d a y  
13. Af te r  d a y  11, v i rus  could no t  be recovered b y  homogeniza t ion  or co-cul t iva t ion  
of b ra in  t issue wi th  L929 or MDCK cells a t  e i ther  25 ° or 35 ° C. Al though  we 
clearly d e m o n s t r a t e d  repl ica t ion  of P 17, we were unable  to  de tec t  a n y  his tological  
changes associa ted wi th  v i rus  repl icat ion.  This  was in sharp  con t ras t  to  infect ion 
wi th  p a r e n t a l  LCMV which showed evidence of meningi t i s  as ear ly  as d a y  4 
post - infect ion.  I n  add i t i on  to an  un remarkab te  his tological  p ic ture ,  an imals  
infected wi th  P17 d id  no t  synthesize  de tec tab le  levels of neut ra l iz ing  an t ibody ,  
a l though  low levels of complement  f ixing a n t i b o d y  were de tec tab le  b y  d a y  7 
pos t - infec t ion  and  the  animals  were res i s tan t  to backehal lenge with  100 LDa0 
(216 P F U )  of pa ren t a l  LCMV (Table 1). His to logica l ly  the  back  challenged mice 
showed a mi ld  meningi t is  by  6 days  post - infect ion t h a t  resolved b y  14 days  
post- infect ion.  W e  could isolate  infect ious vi rus  for only  three  days  pos t  challenge 
in these  mice. 
Table 1. E]]ects of LC31V P17  replication in mice 
Days LCMV P t7 b Complement-fixingc Percent 
post-infection a present in brain ant ibody t i ter  surviving challenge a 
0 @ < 1 : 2  0 ±  0 
1 ~- < 1 : 2  0 ±  0 
2 + < 1 : 2  0~: 0 
3 ~- < 1 : 2  0 ±  0 
4 ~b < 1 : 2  0 ±  0 
5 @ 1:2 0:t: 0 
7 -~ 1 : 4 30±  20 
9 -~ 1:4 40~10  
11 @ 1:4 5 0 i 1 0  
13 -- 1:8 tOOJ: 0 
18 --  1:8 100± 0 
21 --  1:4 1004- 0 
a 1000 P F U  P 17 intracerebral ly 
b Ti t rated in MDCK cells at  25 ° C 
c Titers of sera pooled from ten mice determined using the method of KE~:r and FIFE 
(9) 
a t00 LDs0 parental  LCMV intracerebral ly 
To de te rmine  if in terference phenomena  were responsible  for the  lack  of 
virulence in P17,  w e . a s s a y e d  bo th  an ima l  t issues and  cell cul ture  fluids for 
in ter feron  and  defect ive- in ter fer ing (DI) par t ic les  using publ i shed  procedures  
(4, 14). In t e r fe ron  could be de tec ted  in the  med ium from L929 cul tures  infected 
wi th  p a r e n t a l  LCMV m a i n t a i n e d  a t  35 ° C. In te r fe ron  was no t  de tec ted  in the  
88 P.R. BI~AYTON and H. F. MA.ASSAB : 
medium of L929 cul tures  irtfected with  e i ther  p a r e n t a l  LCMV or P 17 incuba ted  
a t  25 ° C. I n  addi t ion ,  no in ter feron was de tec ted  in b ra in  homogena tes  of animals  
infected i .c.  wi th  ei ther  virus.  Since SW mice do no t  produce  high levels of 
in ter feron (8, 15), th is  resul t  was not  surprising.  To e l iminate  D I  par t ic les  in 
P17,  we made  two high di lut ion passages in L929 cells before p laque  purifi-  
cation.  We checked this  pool  for the  presence of large numbers  of D I  par t ic les  in 
the  med ium b y  p laque  assay  since D I  par t ic les  in high concent ra t ion  cause a 
decrease in LCMV plaques  a t  low di lut ions (I4, 18). This could no t  be demon-  
s t r a t ed  ~dth P I 7 .  
The s t ab i l i t y  of P 17 was examined  by  making  serial  b ra in  passages.  Briefly,  
mice were inocula ted  i .c.  wi th  1000 P F U  of P 17. A t  3 days  post - infect ion,  b ra in  
homogena tes  were p repared  and  were assayed for p laque  fo rmat ion  a t  bo th  25 ° 
and  35 ° C. Af ter  this  t i t ra t ion ,  1000 P F U  was again  inocula ted  i .e.  into a d u l t  
mice. This was repea ted  th ree  t imes.  There  was no increase in virulence with  
passage,  and  the  virus  re ta ined  i ts  inabiliLy to  form plaques  a t  35 ° C. There  were 
no his tological  changes associa ted wi th  the  infection,  and  the  basic growth  
pa rame te r s  out l ined  in Fig.  1 were stable.  The P17  thus  recovered was demon-  
s t r ab ly  LCMV as i t  was neu t ra l ized  b y  r a b b i t  an t i -LCMV serum. Therefore,  we 
have  isola ted f rom the  Arms t rong  s t ra in  of LCNV a s table  va r i an t  t h a t  shows 
a t  leas t  a 1000 fold reduct ion  in virulence for adu l t  mice when compared  to  the  
p a r e n t a l  virus  and  t h a t  is capable  of infectilzg mice and  el iei t ing an  a p p a r e n t l y  
p ro t ec t ive  immune  response.  
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